ESMO podcast

25 October 2021

Shape 1
Featured Image - ESMO podcast

Did you attend ESMO 2021? With lots of insights shared, our Blueprint Partnership Oncology Lead Siobhan Davies has generated a podcast on the big topics and highlights from ESMO.

During the podcast Siobhan explores whether checkpoint inhibitors should be part of neoadjuvant treatment in TNBC and NSCLC, the developments in cervical cancer (a real game changer), and our views on the biggest topics in Oncology.